SEC Form 8-K filed

false 0000876378 0000876378 2021-03-03 2021-03-03

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

 

 

 

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

March 3, 2021
Date of Report (date of earliest event reported)

 

 

635 Davis Drive, Suite 300
Morrisville, North Carolina 27560
(Address of principal executive offices)

 

919-765-8400
(Registrant’s telephone number, including area code)

 

Not Applicable
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.       ☐

 

 

 

Item 8.01          Other Events.

 

On March 3, 2021, Asensus Surgical, Inc., a Delaware corporation, issued a press release to announce that it had received an additional FDA clearance for the Senhance® Surgical System which allows for indication expansion in general surgery in the United States.

 

A copy of the press release is filed herewith as Exhibit 99.1 and incorporated herein by reference.

 

 

Item 9.01         Financial Statements and Exhibits.

 

 

Exhibit No.         Description                                                                                

 

99.1                     Press release dated March 3, 2021

 

104                     Cover Page Interactive Data File (formatted in inline XBRL)

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.